Exchange Compliance. The Company’s common stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed on the OTCQB (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock (including the Shares and Warrant Shares) from the Principal Market. The Company is in compliance with all of the presently applicable requirements for continued listing of the Common Stock on the Principal Market. The issuance of the Securities and the Warrant Shares does not require shareholder approval including, without limitation, pursuant to the rules and regulations of the Principal Market.
Appears in 2 contracts
Samples: Common Stock and Warrant Purchase Agreement (Pacific Grove Capital LP), Common Stock and Warrant Purchase Agreement (Monaker Group, Inc.)
Exchange Compliance. The Company’s common stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed trades on the OTCQB OTC Pink Market (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock common stock under the Exchange Act or delisting the Common Stock common stock (including the Note Shares and Warrant Shares) from the Principal Market. The Company is in compliance with all of the presently applicable requirements for continued listing of the Common Stock common stock on the Principal Market. The issuance of the Securities and the Warrant Shares does not require shareholder approval including, without limitation, pursuant to the rules and regulations of the Principal Market.
Appears in 1 contract
Samples: Secured Convertible Promissory Note Purchase Agreement (EVO Transportation & Energy Services, Inc.)
Exchange Compliance. The Company’s common stock is registered pursuant to Section 12(g12(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed on the OTCQB Nasdaq Capital Market (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock (including the Shares and Warrant Shares) from the Principal Market. The Except as disclosed in the Company SEC Documents, the Company is in compliance with all of the presently applicable requirements for continued listing of the Common Stock on the Principal Market. The issuance of the Securities and the Warrant Shares does not require shareholder stockholder approval including, without limitation, pursuant to the rules and regulations of the Principal Market.
Appears in 1 contract
Exchange Compliance. The Company’s common stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed on the OTCQB OTCQB® Venture Market (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock (including the Shares and Warrant Shares) from the Principal Market. The Company is in compliance with all of the presently applicable requirements for continued listing of the Common Stock on the Principal Market. The issuance of the Securities and the Warrant Shares does not require shareholder approval including, without limitation, pursuant to the rules and regulations of the Principal Market.
Appears in 1 contract
Samples: Common Stock and Warrant Purchase Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp)
Exchange Compliance. The Company’s common stock Common Stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed quoted on the OTCQB operated by OTC Markets Group, Inc. (the “Principal Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock (including the Shares and Warrant Shares) from the Principal Market. The Company is in compliance compliance, in all material respects, with all of the presently applicable requirements for continued listing of the Common Stock on the Principal Market. The issuance of the Securities and the Warrant Shares does not require shareholder stockholder approval including, without limitation, pursuant to the rules and regulations of the Principal Market.
Appears in 1 contract
Exchange Compliance. The Company’s common stock is registered pursuant to Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) and is listed on the OTCQB (the “Principal Nasdaq National Market”), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock common stock under the Exchange Act or delisting the Common Stock common stock (including the Common Shares and Warrant Shares) from the Principal Nasdaq National Market. The Company is in compliance with all of the presently applicable requirements for continued listing of the Common Stock on the Principal Nasdaq National Market. The issuance of the Securities and the Warrant Shares does not require shareholder approval including, without limitation, pursuant to the rules and regulations Nasdaq Marketplace Rules or any other rule of the Principal Nasdaq Stock Market.
Appears in 1 contract
Samples: Common Stock and Warrant Purchase Agreement (Pw Eagle Inc)